MergerLinks Daily Review
MergerLinks
Join a community of 250,000+ M&A professionals. Expand your network and discover new business opportunities.
Welcome to MergerLinks Daily Review. Sign up here to get the full round up of your daily dose of blue-chip M&A news directly to your inbox.
Walgreens explores $4bn-plus sale of Shields Health.
Apollo-backed aerospace supplier Arconic to sell China business in $300m deal. (FS)
You can access today’s complete newsletter here.
Scroll down for more…
Kyowa Kirin, a global speciality pharmaceutical company, completed the acquisition of Orchard Therapeutics, a global gene therapy company, for $478m.
“We are truly excited about the acquisition of Orchard Therapeutics, a leading provider of HSC gene therapy. This platform offers significant potential to deliver more innovative treatments and breakthrough therapies and aligns with our purpose to deliver life-changing value for people living with rare and complex diseases. Going forward, our companies will build on the extensive experience of Orchard’s gene therapy platform and apply it to under-served indications and diseases where we believe it to be scientifically and clinically differentiated,” Masashi Miyamoto, Kyowa Kirin Representative Director, President and CEO.
Kyowa Kirin was advised by 高盛 and Morrison Foerster (led by Gary Mitchel Smith). Orchard Therapeutics was advised by Guggenheim Partners , Goodwin (led by Michael Bison , Jim Matarese , Andrew Goodman and Tevia Pollard ) and Slaughter and May (led by Paul Mudie and Andrew Jolly ). Guggenheim Partners was advised by Paul, Weiss, Rifkind, Wharton & Garrison LLP .
Patrick Industries, a manufacturer and distributor of component products and building materials, completed the acquisition of Sportech, a supplier of premium component solutions to powersports OEMs, from Monomoy Capital Partners, a private equity firm, for $315m.
"Sportech's growth underscores the unique strength of our closely integrated teams and their commitment to our supportive approach as companies make the leap from a family- or founder-led operation to an enterprise with even broader scale and breadth. We are honored to have worked alongside the company's management team to exceed the goals we outlined together, and we are confident they are well-equipped for continued success as they join the Patrick family of brands," Dan Collin, Monomoy Founding Partner and Co-CEO.
领英推荐
Monomoy Capital Partners was advised by Baird (led by Adam Czaia , Thomas Fetzer , Mike Lindemann and Tom Lacy ), Kirkland & Ellis (led by Michael Sartor and David M. Towarnicky ) and MiddleM Creative (led by Jan Morris ).
General Catalyst, a venture capital firm, led a $200m funding in Bilt Rewards, a loyalty program, with participation from Eldridge, Left Lane Capital, Camber Creek and Prosus Ventures.
"Bilt plans to use the new capital toward expanding its Rewards Alliance, which partners with multifamily, single-family, and student housing operators nationwide. It will also go towards bolstering its Neighborhood Rewards program, which aims to help local merchants “connect and build loyalty” with new and existing residents in their community. The company also plans to expand into mortgage payment rewards," Bilt Rewards.
Bilt Rewards was advised by Financial Technology Partners / FT Partners .
Walgreens explores $4bn-plus sale of Shields Health.
Walgreens Boots Alliance , the troubled drug-store chain in turnaround mode, is exploring options including a sale of Shields Health Solutions , the specialty pharmacy business it acquired a majority of three years ago, Bloomberg reported.
The business could be valued at more than $4bn in a sale. Walgreens is working with advisers to scope out interest in Shields Health, which is expected to draw interest from private equity firms and health-care companies.
Apollo-backed aerospace supplier Arconic to sell China business in $300m deal. (FS)
US aerospace supplier Arconic , controlled by private equity firm Apollo Global Management, Inc. , is selling its China business in a deal that could value it at as much as $300m, DealStreetAsia reported.
The Pittsburgh-based company has mandated 高盛 to run the sale.
Interested to find more? Sign up here to get full round up of your daily dose of blue-chip M&A news directly to your inbox.
You can access today’s complete newsletter here.